Singapore: For glaucoma patients, taking daily medication will soon become a thing of the past. With Nanyang Technologic...
Singapore: BioDuro, a PPD Company, has opened a new state-of-the-art laboratory in Shanghai, China, strengthening its ab...
Singapore: Sanofi and Regeneron Pharmaceuticals have received US Food and Drug Administration (FDA) approval for ZALTRAP...
Singapore: Exclusivity is everything in the pharmaceutical brand business. Without it, power over pricing disappears and...
Singapore: Eisai has received orphan drug designation from Japan's Ministry of Labour, Health and Welfare for its multi...
Singapore: Australia-based QRxPharma is proceeding with US FDA to discuss the company's Moxduo new drug application (NDA...
Singapore: Japan-headquartered Daiichi Sankyo has completed patient enrollment in the global Hokusai-VTE phase III study...
Singapore: Daiichi Sankyo and Amplimmune have entered into a strategic collaboration to develop a new therapeutic prote...
Singapore: The independent Data Monitoring Committee (DMC) of the phase III MARQUEE (Met inhibitor ARQ 197 plus Erlotin...
Singapore: Carrying a copy of a gene variant called ApoE4 confers a substantially greater risk for Alzheimer's disease o...
Singapore: US Food and Drug Administration (FDA) and the European Commission have granted orphan drug designation to Boe...
Singapore: Gilead's drug Sovaldi for hepatitis C virus, GlaxoSmithKline/Theravance's Anoro Ellipta for Chronic Obstructi...
Singapore: Johnson & Johnson has acquired Aragon Pharmaceuticals, a privately-held pharmaceutical discovery and deve...
Singapore: A new study published in Restorative Neurology and Neuroscience demonstrates that Chinese herbal medicine Ji-...
Singapore: University College London (UCL) and Japanese pharmaceutical company Eisai, have entered into a new agreement ...
Singapore: Novartis planning to leverage on its R&D pipeline to taste commercial success through 2017. Continuing R&...
Singapore: BRIM Biotechnology has collaborated with Janssen Pharmaceutica to pursue research, development and commercial...
Phylogica, a leading peptide drug discovery company based in Australia, has developed a world-class drug discovery platf...
Singapore: Japanese firm Ono Pharmaceutical and BioFocus, a service division of Galapagos and based in the UK, have sign...
Singapore: Specialty pharmaceutical company Hatchtech successfully completed end-of-phase II (EOP2) consultations with t...
Singapore: Updated results from a phase II study of orteronel, a selective oral 17,20 lyase inhibitor, dosed without pre...
Singapore: China based biotech firm, 3SBio, has partnered with Selecta Biosciences to license out pegsiticase (Uricase P...
Singapore: Patrys, an Australian clinical stage biopharmaceutical company, has completed the initial treatment of the fi...
Singapore: GVK Bio and US-based Onconova Therapeutics entered into a novel joint partnership to develop new drugs for c...
Singapore: Asian Myeloma Network is developing a regional collaboration of medical specialists across Asia to study the ...
Bangalore: New data from a subgroup analysis of the A1chieve study showed that intensifying treatment with NovoMix 30 (B...
Singapore: Boehringer Ingelheim has initiated phase III study (POLO-AML-2) investigating volasertib, a selective and pot...
Singapore: Takeda Global Research & Development Center resubmitted New Drug Applications (NDAs) to the US FDA for al...
Singapore: Phylogica, a public Australian peptide drug discovery company, has achieved a research milestone under its co...
Singapore: Gilead Sciences has successfully progressed phase IV Terisa (Type 2 Diabetes Evaluation of Ranolazine in subj...
Singapore: Global Pharmaceutical company, AstraZeneca plans to integrate Dendrimer drug delivery technology developed by...
Singapore: Mundipharma, global pharmaceutical company with operations in Singapore, has entered into a license agreement...
Singapore: TNI BioTech and Hubei Qianjiang Pharmaceutical, a leading Chinese pharmaceutical company will co-develop new...
Singapore: Drug Discovery company, Evotec has inked a research collaboration and licensing deal with Swiss Pharma compan...
Singapore: Researchers from St Vincent's Institute of Medical Research in Melbourne, Australia, in collaboration with re...
Singapore: Agilent Technologies has introduced the Agilent Automated Card Extraction LC/MS system, a fully integrated in...
Singapore: AMRI has signed a definitive agreement to acquire all the outstanding shares of Cedarburg Pharmaceuticals for...
As a scientist-turned entrepreneur, my journey has taken a long time, with many struggles along the way. For an entrepre...
Singapore: US Food and Drug Administration (FDA) has approved Novartis' Xolair (omalizumab) for the treatment of chronic...
Singapore: The US Food and Drug Administration (FDA) has granted approval for PR610, an anticancer "stealth" drug invent...
Merck announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA (pembrolizumab)monotherapy, the c...
Singapore: AstraZeneca signed a memorandum of understanding (MoU) with the Korea Health Industry Development Institute (...
Singapore: U.S. Food and Drug Administration (FDA) has approved a Supplemental New Drug Application (sNDA), co-developed...
Singapore: Australia based Bionomics is recognized as the Innovative Asian Biotech of the Year at BioPharma Asia Industr...
Singapore: US-based Vertex Pharmaceuticals has received Therapeutic Goods Administration (TGA) of Australia approval of ...
Singapore: Singapore-based Austrianova presented additional safety and efficacy data from a second phase II pancreatic c...
Singapore: Genentech's omalizumab has shown success in reducing disease severity in patients with moderate to severe chr...
Singapore: Phylogica has been granted a new European patent (no. 1793841) entitled: 'Peptide inhibitors of c-Jun dimeriz...
Singapore: Thermo Fisher Scientific and National University of Singapore (NUS) have entered into a strategic alliance to...
Singapore: Biotech company ArQule and Japan-based Daiichi Sankyo have achieved positive results from a randomized, place...
Singapore: Global pharmaceutical firm, Eisai has expanded the marketing and supply agreement between its U.S. subsidiary...
Singapore: Symphogen signed an exclusive worldwide license agreement with Merck in Germany for Sym004, an investigationa...
Singapore: US-based Kinex Pharmaceuticals's application for the Small Entrepreneur Research Assistance Programme has bee...
Singapore: Influenza vaccine (gH1-Qbeta) developed by Singapore's Agency for Science, Technology and Research (A*STAR) a...
Singapore: The US FDA has approved Exjade (deferasirox) for the treatment of chronic iron overload in patients 10 years...
Singapore: Cancer treatments are becoming increasingly personalized, as regulators are approving therapeutics offering s...
Singapore: GlaxoSmithKline (GSK) and Theravance submitted a regulatory application in the European Union for the investi...
Singapore: In an effort to explore biological influences on the varying appearance of autism spectrum disorder (ASD), Dr...
‎Singapore: Australia-based CSL Behring achieved improved pharmacokinetic results for its novel investigational re...
Singapore: Sanofi and US-based Transgene have launched the construction phase of the manufacturing platform dedicated to...
Singapore: Allied Healthcare has achieved positive results in the study of Adapt-treated tissue as a bioprosthetic subst...
Singapore: Australia based Biotron's HIV drug candidate BIT225 has demonstrated its ability to reverse HIV-induced impai...
Singapore: A research team from Case Western Reserve University School of Medicine has discovered an approach that could...
Singapore: Drug development company Charles River Laboratories has marked net sales of $292.9 million in the second quar...
‎Singapore: US based biosimilar therapeutic developer, Coherus BioSciences, has started its Phase 3 trial of CHS-0...
Singapore: A phase III study conducted at the Cincinnati Children's Hospital Medical Center, US, has revealed that pati...
Singapore: Concert Pharmaceuticals entered into a strategic collaboration with Celgene Corporation directed towards deut...
Singapore: Researchers at University of California have found that prenatal exposure to specific combinations of antibod...
Singapore: Europe's CellSeed has withdrawn its application for a centralized marketing authorization for the medicine Or...
Singapore: Australian infectious disease therapy and vaccine development company BioDiem is developing an antimicrobial ...
Singapore: The LUX-Lung 3 Phase III results showed that lung cancer patients taking the novel compound afatinib, an irre...
Singapore: Japan-based Daiichi Sankyo has launched antihypertensive franchise olmesartan medoxomil in Mexico under the n...
Singapore: A new report, launched by the International Osteoporosis Foundation (IOF), shows that osteoporosis is a loomi...
Singapore: Singapore-based TauRx Pharmaceuticals has received equity investment of $31.5 million from Genting Management...
Singapore: Biopharmaceutical company Nanotherapeutics has selected GE Healthcare Life Sciences' FlexFactory biomanufactu...
Singapore: Chemical Heritage Foundation (CHF) and Biotechnology Industry Organization (BIO) have selected Mexican steroi...
Singapore: Austrianova Singapore has established a research cell bank, the first step towards late-phase clinical trials...
Singapore: Japanese companies Dainippon Sumitomo Pharma and Takeda Pharmaceutical have obtained approval for marketing a...
Singapore: Japan's Astellas Pharma has collaborated with US-based Ambrx for the discovery and development of novel antib...
Singapore: Jubilant Biosys, a subsidiary of Bangalore-based Jubilant Life Sciences, has expanded its drug discovery alli...
Singapore: Patrys completed initial treatment of second group of three patients in its phase I/IIa PAT-SM6 multiple myel...
Singapore: AstraZeneca's global biologics R&D arm, MedImmune, plans to acquire Amplimmune, which is a US-based biolo...
Singapore: Biostar Pharmaceuticals, a China-based manufacturer and marketer of pharmaceutical and health supplement prod...
Singapore: Japan-based Otsuka Pharmaceutical and H Lundbeck have received US FDA approval for Abilify Maintena (aripipra...
Singapore: Australia-based Novogen has acquired a novel drug technology that will be developed as a potentially major cl...
Singapore: US Food and Drug Administration (FDA) have issued a complete response letter regarding a supplemental New Dru...
Singapore: Sanofi and the Global Alliance for TB Drug Development (TB Alliance) entered a research collaboration to acce...
Lupin Pharmaceutical, which aims to be the best transnational pharmaceutical company in the world, stroked 10.64 percent...
Singapore: Australian drug delivery technology company Phosphagenics has appointed biotech industry veterans Mr Lawrence...
Singapore: Following successful first-in-man phase I and two phase IIa clinical studies with the oral formulation of fin...
Recent promising data on drug approvals in 2011 shows that there were 35 new molecular entities (NME) approved by the FD...
Singapore: Sweden-based Medivir has discontinued the development of its hepatitis B compound MIV-210 based on a joint de...
Singapore: Eisai revealed its preliminary results from a recently completed phase III study of Halaven versus capecitabi...
Singapore: A study by researchers at the University of Michigan Medical School, US, found that antidepressant drug trany...
Singapore: Australian pharmaceutical company Pharmaxis is all set to launch Bronchitol for cystic fibrosis (CF) patients...
Singapore: UK's Marvel LifeScience, insulin marketing company, has withdrawn its application for centralized marketing a...
Singapore: Alchemia has completed enrollment of patients in a pivotal phase III clinical trial evaluating its lead prod...
Sinapore: Bayer HealthCare in Singapore in collaboration with five research institutions have kaunched new Integrated Tr...
Singapore: Daiichi Sankyo's 24-month randomized, double-blind, placebo-controlled multi-center phase III clinical trial ...
Singapore: Gilead Sciences plans to halt phase III study evaluating idelalisib in previously-treated chronic lymphocytic...
